Clinical Trial Update: Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information: Administrative Supplement Study [Phase 2]

View source ↗

Summary

An administrative supplement update to a Phase 2 clinical trial studying how to understand and address rejection of personalized breast cancer risk information …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Colorado, Denver | Conditions: Breast Cancer Female | Phase 2 | Status: COMPLETED